The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter Syndrome

被引：1
|
作者：
Xia, Leiming
Chen, Qian
Li, Qiao
Li, Tan
Wang, Yi
Bao, Yangyi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT041
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
    Guo, Yelei
    Wang, Yao
    Han, Weidong
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [42] Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
    Hill, Joshua A.
    Li, Daniel
    Hay, Kevin A.
    Green, Margaret L.
    Cherian, Sindhu
    Chen, Xueyan
    Riddell, Stanley R.
    Maloney, David G.
    Boeckh, Michael
    Turtle, Cameron J.
    BLOOD, 2018, 131 (01) : 121 - 130
  • [43] Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy
    Hay, Kevin A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 364 - 374
  • [44] Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy
    Hill, Joshua A.
    Krantz, Elizabeth M.
    Hay, Kevin A.
    Dasgupta, Sayan
    Stevens-Ayers, Terry
    Bender Ignacio, Rachel A.
    Bar, Merav
    Maalouf, Joyce
    Cherian, Sindhu
    Chen, Xueyan
    Pepper, Greg
    Riddell, Stanley R.
    Maloney, David G.
    Boeckh, Michael J.
    Turtle, Cameron J.
    BLOOD ADVANCES, 2019, 3 (22) : 3590 - 3601
  • [45] Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis
    Kaulen, Leon D.
    Karschnia, Philipp
    Doubrovinskaia, Sofia
    Abramson, Jeremy S.
    Martinez-Lage, Maria
    Shankar, Ganesh
    Choi, Bryan D.
    Barnes, Jeffrey A.
    El-Jawahri, Areej
    Hochberg, Ephraim P.
    Johnson, P. Connor
    Soumerai, Jacob D.
    Wick, Wolfgang
    Maus, Marcela V.
    Chen, Yi-Bin
    Frigault, Matthew J.
    Dietrich, Jorg
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2411 - 2415
  • [46] Targeting T-cell Leukemia with CD5-Based Chimeric Antigen Receptor-Modified γδ T Cells
    Fleischer, Lauren C.
    Zoine, Jaquelyn T.
    Ryan, Rebecca E.
    Raikar, Sunil S.
    Doering, Christopher B.
    Spencer, H. Trent
    MOLECULAR THERAPY, 2018, 26 (05) : 57 - 57
  • [47] Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
    Diaconu, Iulia
    Ballard, Brandon
    Zhang, Ming
    Chen, Yuhui
    West, John
    Dotti, Gianpietro
    Savoldols, Barbara
    MOLECULAR THERAPY, 2017, 25 (03) : 580 - 592
  • [48] Chimeric Antigen Receptor-Modified T Cells for the Treatment of Acute Myeloid Leukemia Expressing CD33
    Song, Degang
    Swartz, Michael H.
    Biesecker, Steve G.
    Borda, Fernando
    Shah, Rutul R.
    Emtage, Peter
    Wierda, William G.
    Cooper, Laurence J. N.
    Chan, Tim
    BLOOD, 2016, 128 (22)
  • [49] COMMON TRAJECTORIES OF HIGHLY EFFECTIVE ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS IDENTIFIED BY ENDOGENOUS T CELL RECEPTOR LINEAGES
    Wilson, Taylor
    Kim, Hyunjin
    Crawford, Jeremy
    Chou, Ching-Heng
    Langfitt, Deanna
    Allen, E. Kaitlynn
    Lockey, Timothy
    Meagher, Michael
    Talleur, Aimee
    Gottschalk, Stephen
    Thomas, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A160 - A161
  • [50] Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition
    Turtle, Cameron J.
    Sommermeyer, Daniel
    Berger, Carolina
    Hudecek, Michael
    Shank, David M.
    Steevens, Natalia N.
    Budiarto, Tanya M.
    Karimi, Mandana
    Chaney, Colette N.
    DeVito, Anna Marie
    Heimfeld, Shelly
    Jensen, Michael C.
    Riddell, Stanley R.
    Maloney, David G.
    BLOOD, 2014, 124 (21)
12345